BE902344A - Produits conjugues d'anthracyclines/polymeres anioniques. - Google Patents
Produits conjugues d'anthracyclines/polymeres anioniques.Info
- Publication number
- BE902344A BE902344A BE0/214956A BE214956A BE902344A BE 902344 A BE902344 A BE 902344A BE 0/214956 A BE0/214956 A BE 0/214956A BE 214956 A BE214956 A BE 214956A BE 902344 A BE902344 A BE 902344A
- Authority
- BE
- Belgium
- Prior art keywords
- anionic polymer
- anthracycline
- polymer conjugates
- new
- products
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848413464A GB8413464D0 (en) | 1984-05-25 | 1984-05-25 | Anthracycline-anionic polymer conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
BE902344A true BE902344A (fr) | 1985-09-02 |
Family
ID=10561522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE0/214956A BE902344A (fr) | 1984-05-25 | 1985-05-03 | Produits conjugues d'anthracyclines/polymeres anioniques. |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS6156128A (de) |
BE (1) | BE902344A (de) |
DE (1) | DE3515178A1 (de) |
GB (2) | GB8413464D0 (de) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378456A (en) * | 1993-03-25 | 1995-01-03 | American Cyanamid Company | Antitumor mitoxantrone polymeric compositions |
EP0710689A2 (de) | 1994-11-01 | 1996-05-08 | American Cyanamid Company | Polymerische Antitumormittel |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY103231A (en) * | 1987-03-11 | 1993-05-29 | Univ Melbourne | Immunoglobulin conjugates |
ATE120647T1 (de) * | 1987-05-28 | 1995-04-15 | Hiroshi Maeda | Superoxid-dismutase-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel. |
IT1230505B (it) * | 1988-10-11 | 1991-10-25 | Sicor Spa | Procedimento per la conversione della daunorubicina in doxorubicina. |
JPH03101616A (ja) * | 1989-07-12 | 1991-04-26 | Union Carbide Chem & Plast Co Inc | 製薬学的活性誘導体の放出系 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1602967A (en) * | 1977-07-16 | 1981-11-18 | Hercules Inc | Reaction prodcut of methotrexate with divinyl ether and maleic anhydride copolymer |
-
1984
- 1984-05-25 GB GB848413464A patent/GB8413464D0/en active Pending
-
1985
- 1985-04-22 GB GB08510222A patent/GB2158078B/en not_active Expired
- 1985-04-26 DE DE19853515178 patent/DE3515178A1/de not_active Withdrawn
- 1985-05-03 BE BE0/214956A patent/BE902344A/fr not_active IP Right Cessation
- 1985-05-24 JP JP60110620A patent/JPS6156128A/ja active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378456A (en) * | 1993-03-25 | 1995-01-03 | American Cyanamid Company | Antitumor mitoxantrone polymeric compositions |
EP0710689A2 (de) | 1994-11-01 | 1996-05-08 | American Cyanamid Company | Polymerische Antitumormittel |
Also Published As
Publication number | Publication date |
---|---|
DE3515178A1 (de) | 1985-11-28 |
GB8413464D0 (en) | 1984-07-04 |
GB8510222D0 (en) | 1985-05-30 |
GB2158078B (en) | 1987-09-16 |
JPS6156128A (ja) | 1986-03-20 |
GB2158078A (en) | 1985-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0495265B1 (de) | Säureempfindliche Linkermoleküle | |
JP2740841B2 (ja) | 新規なリンカーを有するアントラサイクリン・イムノコンジュゲート及びその製造方法 | |
AU611196B2 (en) | Modified antibodies for enhanced clearance | |
US5010176A (en) | Antibody-drug conjugates | |
BE902344A (fr) | Produits conjugues d'anthracyclines/polymeres anioniques. | |
JPS61243026A (ja) | 重合性薬剤の製造方法 | |
AU2020188A (en) | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells | |
DK0398305T3 (da) | Anthracyclinkonjugat med en hidtil ukendt linker og fremgangsmåder til fremstilling deraf | |
WO1997012895A1 (fr) | Nouveaux derives de composes d'anthracycline, et preparations medicamenteuses les contenant | |
US5208323A (en) | Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent | |
Zunino et al. | Poly (carboxylic acid) polymers as carriers for anthracyclines | |
GB1446536A (en) | Pharmaceutically active compositions | |
US5776458A (en) | Anthracycline-conjugates | |
Říhová et al. | Action of polymeric prodrugs based on N-(2-hydroxypropyl)-methacrylamide copolymers. II. Body distribution and T-cell accumulation of free and polymer-bound [125I] daunomycin | |
Williamson et al. | Trypanocidal activity of daunorubicin and related compounds | |
Takahashi et al. | Isolation and hypoglycemic activity of saccharans A, B, C, D, E and F, glycans of Saccharum officinarum stalks1 | |
KR100249067B1 (ko) | 안트라사이클린 결합체 및 이의 제조방법 | |
CA1252719A (en) | METHOD FOR THE PREPARATION OF CONJUGATES OF ADENINE-9- .beta.-ARABINOFURANOSIDE 5' MONOPHOSPHATE WITH LACTOSAMINATED HUMAN ALBUMIN, THE CONJUGATES OBTAINED AND THERAPEUTICALLY ACTIVE COMPOSITION CONTAINING THEM | |
Dimitrijevic et al. | Synthesis and characterization of N-(2-Hydroxypropyl)-methacrylamide (HPMA) copolymer-emetine conjugates | |
IL117564A0 (en) | Pharmaceutical and diagnostic compositions containing lysine derivatives | |
OUCHI¹ et al. | Design of Macromolecular Prodrug of ADR Using CM-Chitin as a Carrier | |
Pagé et al. | Daunorubicin-albumin copolymer targeting to phagocytic mouse leukemia cells in vitro and in vivo | |
Ogura et al. | Induction of activated macrophages by IP injection of mitomycin C in rats and mice | |
WO1991001757A1 (en) | Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: FARMITALIA CARLO ERBA S.P.A. Effective date: 19880531 Owner name: ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI T Effective date: 19880531 |